Creative Medical taps CRO Syneos to run Type 1 diabetes cell therapy study Biotech Creative Medical Technology has tapped Syneos to run a phase 1/2 randomized trial of its cell therapy for the potential treatment of Type … See more –> Source Follow LECRAB on twitter Post navigation New device for lower extremity rehabilitation receives FDA approval! – EurekAlert! Health data breach hitting Congress ‘could be extraordinary’ | AP News
